You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Zimmer Biomet announces Q3 2024 quarterly cash dividend
30 August 2024 -

US-based global medical technology company Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) announced on Thursday its quarterly cash dividend for the third quarter of 2024.

The company has declared cash dividend of USD0.24 per share.

The dividend will be paid to shareholders of record at 30 September 2024 on 31 October 2024.

Login
Username:

Password:


Related Headlines

Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion

ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ

Sirum collaborates with Governor Wes Moore to expand medication access across Maryland

Genomma Lab Internacional announces quarterly dividend

Abbott announces quarterly common dividend

West Pharmaceutical Services announces Q2 dividend

Perrigo increases quarterly dividend

AbbVie announces quarterly cash dividend

hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026

OptiBiotix expands into Indian market with Amazon launch

Poxel to receive royalties and sales-based payment from Sumitomo Pharma

ReciBioPharm secures grant to expand RNA manufacturing in LMICs

CVS Health to pays common stock quarterly dividend of USD0.665 per share

TC BioPharm receives shareholders' approval for 25% stock dividend

USANA Health Sciences acquires controlling stake in Hiya Health for USD205m

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025